Blocking kinase could provide treatment for prostate cancer
Researchers have found that inhibiting a kinase in mice leads to the death of prostate cancer cells, providing a potential therapeutic target.
List view / Grid view
Oncology is a branch of medicine that deals with the prevention, diagnosis and treatment of cancer.
Researchers have found that inhibiting a kinase in mice leads to the death of prostate cancer cells, providing a potential therapeutic target.
Researchers have found a molecule, which when deleted, increases leukaemia sensitivity to natural killer cells and is a drug target.
A study has found that removing a particular kind of macrophage enables the immune system to attack tumours, providing a potential drug target.
Researchers have discovered the roles that immune cells play in tumour growth and breast cancer immunotherapy which could aid in drug development.
Researchers have discovered that MYC cancers use the cell’s machinery to make lipids and identified a lipid signature, which could be exploited in the development of new therapies.
The structure of a key receptor involved in tumour metastasis has been imaged in a study, providing opportunities to develop cancer treatments.
A study has revealed a drug target for skin cancers which regulates the differentiation of cells and the roles they conduct in the body.
Researchers have revealed a key inflammation mechanism that contributes to melanoma brain metastasis and could be a therapeutic target.
New findings show that the environment for pancreatic cancers plays a role in its metastasis, revealing a new potential drug target.
A new study has revealed that glioblastomas contain four different types of cell which the researchers say should be treated separately.
Using a compound called PTC596 in combination with other drugs, researchers effectively treated pancreatic cancer in mice.
A study has found that signals from interferons can be blocked, allowing the immune system to attack tumours which provides a potential target.
Researchers have identified the process behind cancer cell energy production, providing a drug target for treatments to inhibit growth.
Researchers have discovered the mechanism behind a gateway into cells for glutamine, illuminating potential ways to prevent cancer cells from getting nutrients.
A study has discovered that reducing expression of a key gene in neuroblastoma tumourigenesis is an important drug target for the condition.